Skip to main content
SpringerLink
Log in

Untersuchungen zur kurzzeitigen Induktions- und zyklischen Erhaltungstherapie beim inoperablen kleinzelligen Bronchialkarzinom

Short-term induction therapy with or without maintenance in inoperable small cell bronchogenic carcinoma

  • Originalien
  • Published:
Klinische Wochenschrift Aims and scope Submit manuscript

Summary

Since July 1978 one hundred and three consecutive patients with unresectable small cell bronchogenic carcinoma were treated with a combination of doxorubicin, cyclophosphamide and vincristine (ACO). In limited disease patients (64) the second chemotherapy course was followed by prophylactic cranial irradiation, the fourth by irradiation towards primary disease sites. Complete responders were randomised to either receive etoposide or no further maintenance therapy. Objective responses were reached in 88/100 evaluable patients, with 72% of complete remissions in limited-stage disease and 33% in extensive disease, respectively. The actuarial median survival time for limited disease patients was 15.8 months compared to 9.3 months in extensive disease (p<0.005). 29 of the 100 patients remain still alive, 4 for more than 24 months without disease recurrence. The survival advantage of patients reaching complete remissions relative to those who did not is highly significant (p<0.001). Acute gastrointestinal and hematological side effects were common, with possibly three drug-related deaths from infections during transient granulocytopenia (mean nadir: 600–900 cells/mm3). The present induction regimen using only four courses of chemotherapy produces high complete remission rates on roentgenography and bronchoscopy and improved survival in the majority of patients. Thus far any effectiveness of etoposide-maintenance therapy following ACO could not be substantiated.

Zusammenfassung

Seit Juli 1978 wurden 103 Patienten mit inoperablem kleinzelligem Bronchialkarzinom mit der Zytostatikakombination Adriamycin, Cyclophosphamid und Vincristin (ACO) behandelt. Im Stadium „limited disease“ (n=64) erfolgte während des zweiten Chemotherapiekurses eine prophylaktische Schädelbestrahlung, nach dem vierten eine konsolidierende thorakale Bestrahlung. Nach Erreichen einer kompletten Remission erhielten die Patienten prospektiv randomisiert Etoposid oder keine weitere spezifische Therapie. Ein objektives Ansprechen konnte bei 88/100 auswertbaren Patienten erzielt werden. Im Stadium „limited disease“ fanden sich 72%, im Stadium „extensive disease“ nur 33% komplette Remissionen. Im Stadium „limited disease“ betrug die hochgerechnete mediane Überlebenszeit 15,8, im Stadium „extensive disease“ 9,3 Monate (p<0.005). Es leben noch 29 Patienten, 4 rezidivfrei länger als 24 Monate. Patienten mit kompletter Remission hatten eine statistisch signifikant (p<0.001) längere Überlebenszeit als Patienten mit geringerem Ansprechen. Regelmäßig traten gastrointestinale und hämatologische Nebenwirkungen auf, drei Patienten starben während der Induktionsphase an Infektionen. Die kurzzeitige Induktionsbehandlung verbesserte jedoch den Krankheitsverlauf subjektiv und objektiv. Bisher ist kein positiver Effekt der zyklischen Etoposid-Gabe nach ACO festzustellen.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Literatur

  1. Abeloff MD, Ettinger DS, Order SE, Khouri N, Mellits ED, Dorschel NT, Baumgardner R (1981) Intensive induction chemotherapy in 54 patients with small cell carcinoma of the lung. Cancer Treat Rep 65:639–646

    Google Scholar 

  2. Aisner J, Wiernik PH (1980) Chemotherapy versus chemoimmunotherapy for small-cell undifferentiated carcinoma of the lung. Cancer 46:2543–2549

    Google Scholar 

  3. Alberto P, Brunner KW, Martz G, Obrecht JP, Sonntag RW (1976) Treatment of bronchogenic carcinoma with simultaneous or sequential combination chemotherapy, including methotrexate, cyclophosphamide, procarbazine and vincristine. Cancer 38:2208–2216

    Google Scholar 

  4. Alexander M, Glatstein EJ, Gordon DS, Daniels JR (1977) Combined modality treatment of oat cell carcinoma of the lung: a randomized trial. Cancer Treat Rep 61:1–6

    Google Scholar 

  5. American Cancer Society (1981) Cancer statistics, 1981. Ca 31:13–28

    Google Scholar 

  6. Aroney RS, Dalley DN, Chan WK, Bell DR, Levi JA (1981) Menigeal carcinomatosis in small cell carcinoma of the lung. Am J Med 71:26–32

    Google Scholar 

  7. Baglan RJ, Marks JE (1981) Comparison of symptomatic and prophylactic irradiation of brain metastases from oat cell carcinoma of the lung. Cancer 47:41–45

    Google Scholar 

  8. Bergsagel DE, Jenkin RDT, Pringle JF, White DM, Fetterly JCM, Klaassen DJ, McDermot RSR (1972) Lung cancer: Clinical trial of radiotherapy alone vs. radiotherapy plus cyclophosphamide. Cancer 30:621–627

    Google Scholar 

  9. Blum U, Ungeheuer E, Wacha H, Kiel G (1981) Ist die chirurgische Therapie beim kleinzelligen Bronchialkarzinom heute noch indiziert? Dtsch Med Wochenschr 106:1286–1288

    Google Scholar 

  10. Bradley WG, Lassmann LP, Pearce GW, Walton JN (1970) The neuromyopathy of vincristine in man. Clinical, electrophysiological and pathological studies. J Neurol Sci 10:107–131

    Google Scholar 

  11. Breslow N (1974) Covariance analysis of censored survival data. Biometrics 30:89–99

    Google Scholar 

  12. Byhardt RW, Libnoch JA, Cox JD, Holoye PY, Kun L, Komaki R, Clowry L (1981) Local control of intrathoracic disease with chemotherapy and role of prophylactic cranial irradiation in small-cell carcinoma of the lung. Cancer 47:2239–2246

    Google Scholar 

  13. Catane R, Schwade JG, Yarr I, Lichter AS, Tepper JE, Dunnick NR, Brody L, Brereton HD, Cohen M, Glatstein E (1981) Follow-up neurological evaluation in patients with small cell lung carcinoma treated with prophylactic cranial irradiation and chemotherapy. Int J Radiat Oncol Biol Phys 7:105–109

    Google Scholar 

  14. Cohen MH, Ihde DC, Bunn PA jr, Fossieck BE jr, Matthews MJ, Shackney SE, Johnston-Early A, Makuch R, Minna JD (1979) Cyclic alternating combination chemotherapy for small cell bronchogenic carcinoma. Cancer Treat Rep 63:163–170

    Google Scholar 

  15. Cohen MH, Lichter AS, Bunn PA, Glatstein EJ, Ihde DC, Fossieck BE, Matthews MJ, Minna JD (1980) Chemotherapyradiation therapy (CT-RT) versus chemotherapy (CT) in limited small cell lung cancer (SCLC). In: Hansen HH, Dombernowsky P (eds) II. World conference on lung cancer, Abstracts. Excerpta Medica, Amsterdam Oxford Princeton, p 146

    Google Scholar 

  16. Corbett TH, Griswold DP, Mayo JG, Laster WR, Schabel FM jr (1975) Cyclophosphamide-adriamycin combination chemotherapy of transplantable murine tumors. Cancer Res 35:1568–1573

    Google Scholar 

  17. Cox JD, Yesner R, Mietlowski W, Petrovich Z (1979) Influence of cell type on failure pattern after irradiation for locally advanced carcinoma of the lung. Cancer 44:94–98

    Google Scholar 

  18. Cutler SJ, Ederer F (1958) Maximum utilization of the life table method in analyzing survival. J Chron Dis 8:699–712

    Google Scholar 

  19. DeVita VT, Young RC, Canellos GP (1975) Combination versus single agent chemotherapy: a review of the basis for selection of drug treatment of cancer. Cancer 35:98–110

    Google Scholar 

  20. DeWys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR, Cohen MH, Douglass HO jr, Engstrom PF, Ezdinli EZ, Horton J, Johnson GJ, Moertel CG, Oken MM, Perlia C, Rosenbaum C, Silverstein MN, Skeel RT, Sponzo RW, Tormey DC (1980) Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am J Med 69:491–497

    Google Scholar 

  21. Eagan RT, Frytak S, Nichols WC, Ingle JN, Creagan ET, Kvols LK (1981) Cyclophosphamide and VP-16-213 with or without cis-platin in squamous cell and small cell lung cancers. Cancer Treat Rep 65:453–458

    Google Scholar 

  22. Fox RM, Woods RL, Brodie GN, Tattersall MHN (1980) A randomized study: Small cell anaplastic lung cancer treated by combination chemotherapy and adjuvant radiotherapy. Int J Radiat Oncol Biol Phys 6:1083–1085

    Google Scholar 

  23. Freise G, Gabler A, Liebig S (1978) Bronchial carcinoma and long-term survival. Retrospective study of 433 patients who underwent resection. Thorax 33:228–234

    Google Scholar 

  24. Garfinkel L (1981) Time trends in lung cancer mortality among nonsmokers and a note on passive smoking. J Natl Cancer Inst 66:1061–1066

    Google Scholar 

  25. Ginsberg SJ, Comis RL, Gottlieb AJ, King GB, Goldberg J, Zamkoff K, Elbadawi A, Meyer JA (1979) Long-term survivorship in small-cell anaplastic lung carcinoma. Cancer Treat Rep 63:1347–1349

    Google Scholar 

  26. Greco FA, Richardson RL, Snell JD, Stroup SL, Oldham RK (1979) Small cell lung cancer. Complete remission and improved survival. Am J Med 66:625–630

    Google Scholar 

  27. Gropp C, Havemann K, Scheuer A (1980) Ectopic hormones in lung cancer patients at diagnosis and during therapy. Cancer 46:347–354

    Google Scholar 

  28. Hansen HH, Dombernowsky P, Hirsch FR (1978) Staging procedures and prognostic features in small cell anaplastic bronchogenic carcinoma. Semin Oncol 5:280–287

    Google Scholar 

  29. Hansen HH, Dombernowsky P, Hirsch FR, Hansen M, Rygård J (1980) Prophylactic irradiation in bronchogenic small cell anaplastic carcinoma. A comparative trial of localized versus extensive radiotherapy including prophylactic brain irradiation in patients receiving combination chemotherapy. Cancer 46:279–284

    Google Scholar 

  30. Higgins GA, Shields TW, Keehn RJ (1975) The solitary pulmonary nodule. Ten-year follow-up of Veterans Administration-Armed Forces cooperative study. Arch Surg 110:570–575

    Google Scholar 

  31. Hoffmann PC, Golomb HM, Bitran JD, DeMeester TR, Cohen L, Griem ML, Cooksey JA, Mintz U, Gordon LI, Desser RK, Kinnealey AE, Sovik CA (1980) Small-cell carcinoma of the lung: a five-year experience with combined modality therapy. Cancer 46:2550–2556

    Google Scholar 

  32. Holoye PY, Samuels ML, Lanzotti VJ, Smith T, Barkley HT jr (1977) Combination chemotherapy and radiation therapy for small cell carcinoma. JAMA 237:1221–1224

    Google Scholar 

  33. Høst H (1973) Cyclophosphamide (NSC-26271) as adjuvant to radiotherapy in the treatment of unresectable bronchogenic carcinoma. Cancer Chemother Rep 4(3):161–164

    Google Scholar 

  34. Hyde L, Yee J, Wilson R, Patno ME (1965) Cell type and the natural history of lung cancer. JAMA 193:140–142

    Google Scholar 

  35. Ihde DC, Cohen MH, Bernath AM, Matthews MJ, Bunn PA, Minna JD (1978) Serial fiberoptic bronchoscopy during chemotherapy for small cell carcinoma of the lung. Chest 74:531–536

    Google Scholar 

  36. Jackson DV, Richards II F, Cooper R, Ferree C, Muss HB, White DR, Spurr CL (1977) Prophylactic cranial irradiation in small cell carcinoma of the lung. A randomized study. JAMA 237:2730–2733

    Google Scholar 

  37. Jamshidi K, Swaim WR (1971) Bone marrow biopsy with unaltered architecture: a new bipsy device. J Lab Clin Med 77:335–342

    Google Scholar 

  38. Johnson RE, Brereton HD, Kent CH (1976) Small-cell carcinoma of the lung: attempt to remedy causes of past therapeutic failure. Lancet 2:289–291

    Google Scholar 

  39. Joss R, Kapanci Y, Widmann JJ, Brunner KW, Alberto P (1981) Langfristig tumorfrei überlebende Patienten mit anaplastischem kleinzelligen Bronchialkarzinom. Schweiz Med Wochenschr 111:1282–1286

    Google Scholar 

  40. Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Statist Ass 53:457–481

    Google Scholar 

  41. Karnofsky DA, Abelmann WH, Craver LF, Burchenal JH (1948) The use of the nitrogen mustards in the palliative treatment of carcinoma. With particular reference to bronchogenic carcinoma. Cancer 1:634–656

    Google Scholar 

  42. Kimura I, Nakata Y, Hiraki S (1980) Chemotherapy of small cell lung carcinoma. In: Hansen HH, Dombernowsky P (eds) II. World conference on lung cancer, Abstracts. Excerpta Medica, Amsterdam Oxford Princeton, p 156

    Google Scholar 

  43. Komaki R, Cox JD, Whitson W (1981) Risk of brain metastasis from small cell carcinoma of the lung related to length of survival and prophylactic irradiation. Cancer Treat Rep 65:811–814

    Google Scholar 

  44. Kreyberg L, Liebow AA, Uehlinger EA (1967) Histological typing of lung tumours. World Health Organization, Geneva

    Google Scholar 

  45. Lanzotti VJ, Thomas DR, Boyle LE, Smith TL, Gehan EA, Samuels ML (1977) Survival with inoperable lung cancer. An integration of prognostic variables based on simple clinical criteria. Cancer 39:303–313

    Google Scholar 

  46. Livingston RB, Moore TN, Heilbrun L, Bottomley R, Lehane D, Rivkin SE, Thigpen T (1978) Small-cell carcinoma of the lung: combined chemotherapy and radiation. A Southwest Oncology Group study. Ann Int Med 88:194–199

    Google Scholar 

  47. Lowenbraun S, Bartolucci A, Smalley RV, Lynn M, Krauss S, Durant JD and the southeastern cancer study group (1979) The superiority of combination chemotherapy over single agent chemotherapy in small cell lung carcinoma. Cancer 44:406–413

    Google Scholar 

  48. Mantel N (1967) Ranking procedures for arbitrarily restricted observation. Biometrics 33:65–78

    Google Scholar 

  49. Matthews MJ (1973) Morphologic classification of bronchogenic carcinoma. Cancer Chemother Rep 4(3):299–302

    Google Scholar 

  50. Mattson K, Holsti LR (1980) Prognostic value of doubling time in lung cancer. Strahlentherapie 156:632–636

    Google Scholar 

  51. Maurer LH, Tulloh M, Weiss RB, Blom J, Leone L, Glidewell O, Pajak TF (1980) A randomized combined modality trial in small cell carcinoma of the lung. Comparison of combination chemotherapy-radiation therapy versus cyclophosphamide-radiation therapy effects of maintenance chemotherapy and prophylactic whole brain irradiation. Cancer 45:30–39

    Google Scholar 

  52. Maurer LH, Pajak TF (1981) Prognostic factors in small cell carcinoma of the lung: a Cancer and Leukemia Group B study. Cancer Treat Rep 65:767–774

    Google Scholar 

  53. McMahon LJ, Herman TS, Manning MR, Dean JC (1979) Patterns of relapse in patients with small cell carcinoma of the lung treated with adriamycin-cyclophosphamide chemotherapy and radiation therapy. Cancer Treat Rep 63:359–362

    Google Scholar 

  54. Medical Research Council (1979) Radiotherapy alone or with chemotherapy in the treatment of small-cell carcinoma of the lung. Br J Cancer 40:1–10

    Google Scholar 

  55. Miller AB, Hoogstraten B, Staquet M, Winkler A (1981) Reporting results of cancer treatment. Cancer 47:207–214

    Google Scholar 

  56. Mountain CF (1978) Clinical biology of small cell carcinoma: relationship to surgical therapy. Semin Oncol 5:272–279

    Google Scholar 

  57. Muggia FM, Krezoski SK, Hansen HH (1974) Cell kinetic studies in patients with small cell carcinoma of the lung. Cancer 34:1683–1690

    Google Scholar 

  58. Niederle N, Schmidt CG, Seeber S (1980) Nichtoperative Therapie des Bronchialkarzinoms. Int Welt 3:359–368

    Google Scholar 

  59. Niederle N, Nakhosteen JA, Maassen W, Seeber S (1981a) Advanced bronchogenic carcinoma — control of therapy by bronchoscopy. In: Nakhosteen JA, Maassen W (eds) Bronchology: Research, diagnostic and therapeutic aspects. Martinus Nijhoff Publ, The Hague Boston London, pp 367–370

    Google Scholar 

  60. Nicderle N, Krischke W, Schmidt CG, Seeber S (1981b) Vindesine plus cisplatin chemotherapy in recurrent and primarily resistant small cell bronchogenic carcinoma. In Brade W, Nagel GA, Seeber S (eds) Proceedings of the international vinca alkaloid symposium-vindesine. S. Karger, Basel München Paris London New York Sydney, pp 314–319

    Google Scholar 

  61. Nugent JL, Bunn PA jr, Matthews MJ, Ihde DC, Cohen MH, Gazdar A, Minna JD (1979) CNS metastases in small cell bronchogenic carcinoma. Increasing frequency and changing pattern with lengthening survival. Cancer 44:1885–1893

    Google Scholar 

  62. Pettengill OS, Sorenson GD, Wurster-Hill DH, Curphey TJ, Noll WW, Cate CC, Maurer LH (1980) Isolation and growth characteristics of continuous cell lines from small-cell carcinoma of the lung. Cancer 45:906–918

    Google Scholar 

  63. Pickren JW, Vincent RG (1979) Effect of therapy in lung cancer: an autopsy study. In: Muggia F, Rozencweig M (eds) Lung Cancer: Progress in therapeutic research. Raven Press, New York, pp 151–154

    Google Scholar 

  64. Razek A, Vietti T, Valeriote F (1974) Optimum time sequence for the administration of vincristine and cyclophosphamide in vivo. Cancer Res 34:1857–1861

    Google Scholar 

  65. Saugier B, Brunat M, Cordier JF, Gerard JP, Dorsit G, Marchandise JF, Bastidon R, Perol M, Brune J, Galy P (1978) Cancer pulmonaire à “petites cellules”. Résultats de l'association adriamycine-vincristine-cyclophosphamide chez 38 patients. Nouv Presse Méd 7:1357–1361

    Google Scholar 

  66. Schneiderman MA, Levin DL (1972) Trends in lung cancer. Mortality, incidence, diagnosis, treatment, smoking, and urbanization. Cancer 30:1320–1325

    Google Scholar 

  67. Seeber S, Schmidt CG, Holfeld H, Scherer E (1977) Integrale Behandlung (Chemo- und Radiotherapie) des inoperablen Bronchialkarzinoms. Vorläufige Ergebnisse bei 50 Patienten. Dtsch Med Wochenschr 102:147–152

    Google Scholar 

  68. Seeber S, Niederle N, Schilcher RB, Schmidt CG (1980) Adriamycin, Cyclophosphamid und Vincristin (“ACO”) beim kleinzelligen Bronchialkarzinom. Verlaufsanalyse und Langzeitergebnisse. Onkologie 3:5–11

    Google Scholar 

  69. Seeber S, Higi M, Niederle N, Schmidt CG (1981) Individualisierte Intervallverkürzung bei der chemotherapeutischen Induktionsbehandlung solider Tumoren. Dtsch Med Wochenschr 106:1741–1744

    Google Scholar 

  70. Shank B, Natale RB, Hilaris BS, Wittes RE (1981) Treatment of small cell carcinoma of lung with combined high dose mediastinal irradiation, whole brain prophylaxis and chemotherapy. Int J Radiat Oncol Biol Phys 7:469–475

    Google Scholar 

  71. Sierocki JS, Hilaris BS, Hopfan S, Martini N, Barton D, Golbey RB, Wittes RE (1979) cis-dichlorodiammineplatinum(II) and VP-16-213: an active induction regimen for small cell carcinoma of the lung. Cancer Treat Rep 63:1593–1597

    Google Scholar 

  72. Sobin LH (1979) The WHO histological classification of lung tumors. In: Muggia F, Rozencweig M (eds) Lung cancer: progress in therapeutic research. Raven Press, New York, pp 83–90

    Google Scholar 

  73. Straus MJ (1974) The growth characteristics of lung cancer and its application to treatment design. Semin Oncol 1:167–174

    Google Scholar 

  74. Valaitis J, Warren S, Gamble D (1981) Increasing incidence of adenocarcinoma of the lung. Cancer 47:1042–1046

    Google Scholar 

  75. Valdivieso M, Tenczynski TF, Rodriguez V, Burgess MA, Mountain CF, Barkley HT, Hersh EM, Bodey GP (1981) Chemoimmunotherapy of small cell bronchogenic carcinoma with VP-16-213, ifosfamide, vincristine, adriamycin, and corynebacterium parvum. Cancer 48:238–244

    Google Scholar 

  76. Van Houtte P, Tancini G, De Jager R, Lustman-Maréchal J, Milani F, Bonadonna G, Kenis Y (1979) Small cell carcinoma of the lung: a combined modality treatment. Eur J Cancer 15:1159–1165

    Google Scholar 

  77. Vincent RG, Pickren JW, Lane WW, Bross I, Takita H, Houten L, Gutierrez AC, Rzepka T (1977) The changing histopathology of lung cancer. A review of 1682 cases. Cancer 39:1647–1655

    Google Scholar 

  78. Vincent RG, Wilson HE, Lane WW, Chen TY, Raza S, Gutierrez AC, Caracandas JE (1981) Progress in the chemotherapy of small cell carcinoma of the lung. Cancer 47:229–235

    Google Scholar 

  79. Weiss W, Boucot KR, Cooper DA (1970) The histopathology of bronchogenic carcinoma and its relation to growth rate, metastasis, and prognosis. Cancer 26:965–970

    Google Scholar 

  80. Wellens W, Mussgnug G, Habets L, Schäfer E, Westerhausen M (1980) Die Kombination Ifosfamid/VP 16-213 bei der Therapie des kleinzelligen Bronchialkarzinoms und anderer Malignome. In: Burkert H, Nagel GA (Hrsg) Neue Erfahrungen mit Oxazaphosphorinen unter besonderer Berücksichtigung des Uroprotektors Uromitexan. S. Karger, Basel München Paris London New York Sydney, S 84–90

    Google Scholar 

  81. Young JA, Dillman RO, Taetle R, Seagren SL, Royston I, Lehar TJ (1981) Induction chemotherapy, consolidation radiotherapy, and cross-over chemotherapy for small cell carcinoma of the lung (SCCL). Proc Am Assoc Cancer Res & Am Soc Clin Oncol 22:494

    Google Scholar 

  82. Zelen M (1973) Keynote address on biostatistics and data retrieval. Cancer Chemother Rep 4(3):31–42

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Innere Universitäts- und Poliklinik (Tumorforschung) und Strahlenklinik des Radiologischen Zentrums Westdeutsches Tumorzentrum Essen, Germany

    N. Niederle, W. Krischke, U. Schulz, C. G. Schmidt & S. Seeber

Authors
  1. N. Niederle
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W. Krischke
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. U. Schulz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. G. Schmidt
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. Seeber
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Vorliegende Untersuchungen wurden gefördert im Rahmen des Forschungsprogramms „Arzneimittelentwicklung und -testung für die Krebstherapie“ des BMFT

Rights and permissions

Reprints and permissions

About this article

Cite this article

Niederle, N., Krischke, W., Schulz, U. et al. Untersuchungen zur kurzzeitigen Induktions- und zyklischen Erhaltungstherapie beim inoperablen kleinzelligen Bronchialkarzinom. Klin Wochenschr 60, 829–838 (1982). https://doi.org/10.1007/BF01728349

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01728349

Key words

Schlüsselwörter

Search

Navigation